AIFF
FIREFLY NEURO (AIFF)
NASDAQ
$1.31-$0.005 (-0.38%)
Price as of Jun 23, 2026 7:18 PM EDT
  • $20.7M
    Market Cap
  • -53.38%
    1-Year Change
  • Software - Application
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 7
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

Firefly Neuroscience researchers have developed a new method to accurately differentiate between subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia in Alzheimer's patients using a combination of EEG/ERP and volumetric MRI data.

06/20/2025, 7:45 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$1.30
$1.35
$1.31
1-Year Range
$0.64
$3.16
$1.31
Latest Close$1.31
Change
-$0.02 (-1.53%)
Volume112,570
Market Cap$20.7M
Shares Outstanding15.6M
P/E (TTM)-2.08
Diluted EPS (TTM)-$0.64
Enterprise Value$17.6M

Information as of 06/23/2026

Company Profile

FIREFLY NEUROSCIENCE INC
FIREFLY NEUROSCIENCE INC
https://fireflyneuro.com
$20.7M
Market Cap
-$9.0M
Net Income
Sector: Technology
Industry: Software - Application
1100 Military Road, Kenmore, NY, United States, 14217
888 237 6412

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Key Executives

  • Greg Lipschitz
  • David DeCaprio
  • Gil Issachar
  • Paul Krzywicki

Current Ownership Distribution

  • Other7.0M (44.81%)
  • Institutions4.1M (26.23%)
  • Insiders2.7M (17.05%)
  • Mutual Funds1.9M (11.91%)